•
Jun 30, 2024

Ensign Group Q2 2024 Earnings Report

Ensign Group reported record results and raised annual earnings and revenue guidance.

Key Takeaways

The Ensign Group reported a strong second quarter in 2024, with a 12.5% increase in consolidated GAAP and adjusted revenue, reaching $1.04 billion. GAAP diluted earnings per share were $1.22, and adjusted diluted earnings per share were $1.32. The company also raised its annual earnings guidance to between $5.38 to $5.50 per diluted share and revenue guidance to between $4.20 billion to $4.22 billion.

GAAP net income increased by 11.0% over the prior year quarter, reaching $71.0 million.

Consolidated GAAP and adjusted revenue increased by 12.5% over the prior year quarter, totaling $1.04 billion.

Same Facilities occupancy increased by 2.8% over the prior year quarter, reaching 80.8%.

The company raised its annual 2024 earnings guidance to between $5.38 and $5.50 per diluted share and revenue guidance to between $4.20 billion and $4.22 billion.

Total Revenue
$1.04B
Previous year: $921M
+12.5%
EPS
$1.32
Previous year: $1.16
+13.8%
Occupancy percentage
80.1%
Previous year: 78%
+2.7%
Gross Profit
$142M
Previous year: $149M
-4.5%
Cash and Equivalents
$477M
Previous year: $420M
+13.7%
Free Cash Flow
$41.7M
Total Assets
$4.44B
Previous year: $3.95B
+12.3%

Ensign Group

Ensign Group

Ensign Group Revenue by Segment

Forward Guidance

The company raised and narrowed its annual 2024 earnings guidance to between $5.38 to $5.50 per diluted share, up from $5.29 to $5.47 per diluted share, and increased its annual revenue guidance to between $4.20 billion to $4.22 billion, up from its previous guidance of $4.13 billion to $4.17 billion.

Positive Outlook

  • Solid skilled mix and occupancy growth.
  • Continued strength from recent acquisitions.
  • New midpoint of 2024 earnings guidance represents an increase of more than 14% of 2023 results.
  • New midpoint of 2024 earnings guidance is 31% higher than 2022 results.
  • Confidence in partners' ability to manage and innovate while balancing the addition of newly acquired operations.

Challenges Ahead

  • Guidance assumes normalized health insurance costs.
  • Guidance assumes current expectations regarding reimbursement rates.
  • Guidance excludes certain charges that arise outside of the business.
  • Guidance excludes acquisition-related costs.
  • Guidance excludes share-based compensation.